Patients-Controlled Epidural Analgesia After Gastric Bypass for Morbid Obesity Using Morphine-Levobupivacaine Regimens
NCT01249872 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 96
Last updated 2013-07-24
Summary
Adequate postoperative analgesia can facilitate recovery following gastric bypass surgery for morbid obesity. The efficacy and safety of intravenous patient - controlled analgesia has been studied, but up to date no data are available concerning the use of thoracic epidural patient-controlled analgesia regarding the use of levobupivacaine combined with morphine in morbidly obese patients. The investigators' aim in this prospective, randomized, double-blinded study was to compare the analgesic effectiveness, the dose requirements and side effects of thoracic epidural patient controlled analgesia 0.1% and 0.2% levobupivacaine combined with a continuous epidural administration of morphine, with or without a loading dose, after open gastric bypass for morbid obesity.
Conditions
- Morbid Obesity
- Postoperative Pain
- Postoperative Bowel Function
- Postoperative Ambulation
Interventions
- DRUG
-
GROUP A : 0 mg MORPHINE-0.1% LEVOBUPIVACAINE
Patients receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose 2 ml of normal saline, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA) of 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.
- DRUG
-
GROUP B : 1 mg MORPHINE- 0.1% LEVOBUPIVACAINE
Patients receive intraoperatively(45 min before the estimated end of the surgery)an epidural bolus dose of 1mg of morphine.Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA) of 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.
- DRUG
-
GROUP C : 2 mg MORPHINE-0.1% LEVOBUPIVACAINE
Patients receive intraoperatively (45 min before the estimated end of the surgery) a bolus dose 2 mg of morphine, epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA) of 0.1% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.
- DRUG
-
GROUP D : 0 mg MORPHINE- 0.2% LEVOBUPIVACAINE
Patients receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 2 ml of normal saline epidurally. Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA) of 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.
- DRUG
-
GROUP E : 1 mg MORPHINE-0.2 % LEVOBUPIVACAINE
Patients receive intra-operatively (45 min before the estimated end of the surgery) a bolus dose of 1mg of morphine, epidurally.Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA) of 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.
- DRUG
-
GROUP F : 2 mg MORPHINE- 0.2% LEVOBUPIVACAINE
Patients receive an epidural bolus dose of 2 mg of morphine intra-operatively (45 min before the estimated end of the surgery).Postoperatively, immediately after extubation, patients receive patient controlled epidural analgesia (PCEA) of 0.2% levobupivacaine (5ml, lockout interval 10min) combined with a continuous epidural infusion of morphine 0.2 mg/h.
Sponsors & Collaborators
-
University of Patras
lead OTHER
Principal Investigators
-
KRITON S FILOS, MD, PhD, PROFESSOR · Department of Anesthesiology and Critical Care
-
ATHINA SIAMPALIOTH, MD · University Hospital of Patras
-
ANASTASIA ZOTOU, MD · University Hospital of Patras
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2012-08-31
- Completion
- 2012-09-30
Countries
- Greece
Study Locations
More Related Trials
-
Intraperitoneal Instillation of Levobupivacaine With Morphine Versus Levobupivacaine With Magnesium Sulfate for Postoperative Analgesia
NCT05281081 ·Status: COMPLETED ·Phase: PHASE4
-
IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery
NCT01180660 ·Status: COMPLETED ·Phase: NA
-
Clinical Proposal for the Comparison of Intraperitoneal Anesthetic to Injected Local Anesthetic
NCT00508976 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Exparel to Marcaine in Post-Surgical Analgesia in Bariatrics
NCT02752230 ·Status: WITHDRAWN ·Phase: PHASE4
-
Intraoperative Lidocaine and Combined With Ketamine on Opioid After Bariatric Surgery
NCT04524130 ·Status: COMPLETED ·Phase: PHASE4
-
Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients
NCT01944098 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy
NCT05017246 ·Status: TERMINATED ·Phase: PHASE2
-
Intravenous Lidocaine in Bariatric Surgery.
NCT03211455 ·Status: COMPLETED ·Phase: PHASE3
-
Levobupivacaine Prolonged Wound Infusion for Postoperative Pain Relief After Breast Surgery
NCT02035904 ·Status: UNKNOWN ·Phase: PHASE4
-
Spinal Bupivacaine/Morphine in Laparoscopic Gastro-intestinal Surgery
NCT02284282 ·Status: COMPLETED ·Phase: NA
-
Effect of Body-mass Index (BMI) on Median Effective Dose of Intrathecal Hyperbaric Bupivacaine
NCT01291186 ·Status: COMPLETED ·Phase: NA
-
Bupivacaine Liposomes or Bupivacaine for CMB on Postoperative Analgesia in Laparoscopic Hepatobiliary Pancreatic Surgery
NCT06737341 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
PVB vs PECS Block in Breast Surgery
NCT02677571 ·Status: COMPLETED ·Phase: NA
-
Use of Exparel for Postoperative Analgesia Following Bariatric Surgery
NCT03975283 ·Status: UNKNOWN ·Phase: PHASE4
-
Bilateral Retromuscular Rectus Sheath Block Catheters Usage for Early Postoperative Analgesia After Laparotomic Gastrectomy.
NCT05592496 ·Status: UNKNOWN ·Phase: NA
-
Analgesia iv vs Epidural Analgesia vs Port-sites Infiltration After Laparoscopic Sleeve Gastrectomy
NCT02662660 ·Status: COMPLETED ·Phase: PHASE3
-
Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery
NCT06704698 ·Status: RECRUITING ·Phase: NA
-
Local Anesthetic Infiltration to Prevent Postoperative Pain After Lumbar Surgery
NCT00825422 ·Status: COMPLETED ·Phase: PHASE3
-
A Preemptive Epidural Ropivacaine for Postoperative Pain Relief in Degenerative Lumbar Spine Surgery
NCT01117610 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Dexmedetomidine VS Magnesium Sulphate With Bupivacaine in Erector Spinae Block for Thoracotomy Pain
NCT05851768 ·Status: RECRUITING ·Phase: NA
-
Analgesia for Thyroidectomy Using Bilateral Superficial Cervical Plexus Block With Bupivacaine Only or Adding Ketorolac to it.
NCT05180214 ·Status: COMPLETED ·Phase: PHASE2
-
Spinal Anesthesia For Enhanced Recovery After Liver Surgery
NCT03715517 ·Status: RECRUITING ·Phase: NA
-
Epidural Versus Wound Infusion Plus Morphine Bolus in Open Abdominal Aortic Aneurysm Repair
NCT02677532 ·Status: COMPLETED ·Phase: PHASE4
-
Bupivacaine Liposomal Injection (Exparel) for Postsurgical Analgesia in Patient Undergoing Laparoscopic Bariatric Surgery
NCT02969187 ·Status: COMPLETED ·Phase: PHASE4
-
Thoracic Paravertebral Block for Postoperative Analgesia After Video-assisted Thoracic Surgery.
NCT01082744 ·Status: COMPLETED ·Phase: PHASE3